Article Details

Vaccinex, Inc. Announces Research Collaboration Employing ActivMAb Platform Technology and ...

Retrieved on: 2018-01-08 02:00:00

Tags for this article:

Click the tags to see associated articles and topics

Vaccinex, Inc. Announces Research Collaboration Employing ActivMAb Platform Technology and .... View article details on hiswai:

Excerpt

<div>(MENAFN Editorial) ROCHESTER, N.Y., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the development of therapeutic monoclonal antibodies to treat patients with cancer and neurodegenerative diseases, announces it has ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo